Serum AKR1B10 as an indicator of unfavorable survival of hepatocellular carcinoma
ConclusionsSerum AKR1B10 is a new prognostic marker of HCC, better than AFP.
Source: Journal of Gastroenterology - Category: Gastroenterology Source Type: research
More News: Cancer & Oncology | Carcinoma | Children | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer | Study